Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 3 de 3
Filtrer
Plus de filtres










Base de données
Gamme d'année
1.
Cancer Res ; 77(5): 1188-1199, 2017 03 01.
Article de Anglais | MEDLINE | ID: mdl-28031227

RÉSUMÉ

Head and neck squamous cell carcinomas (HNSCC) exhibiting resistance to the EGFR-targeting drug cetuximab poses a challenge to their effective clinical management. Here, we report a specific mechanism of resistance in this setting based upon the presence of a single nucleotide polymorphism encoding EGFR-K521 (K-allele), which is expressed in >40% of HNSCC cases. Patients expressing the K-allele showed significantly shorter progression-free survival upon palliative treatment with cetuximab plus chemotherapy or radiation. In several EGFR-mediated cancer models, cetuximab failed to inhibit downstream signaling or to kill cells harboring a high K-allele frequency. Cetuximab affinity for EGFR-K521 was reduced slightly, but ligand-mediated EGFR activation was intact. We found a lack of glycan sialyation on EGFR-K521 that associated with reduced protein stability, suggesting a structural basis for reduced cetuximab efficacy. CetuGEX, an antibody with optimized Fc glycosylation targeting the same epitope as cetuximab, restored HNSCC sensitivity in a manner associated with antibody-dependent cellular cytotoxicity rather than EGFR pathway inhibition. Overall, our results highlight EGFR-K521 expression as a key mechanism of cetuximab resistance to evaluate prospectively as a predictive biomarker in HNSCC patients. Further, they offer a preclinical rationale for the use of ADCC-optimized antibodies to treat tumors harboring this EGFR isoform. Cancer Res; 77(5); 1188-99. ©2016 AACR.


Sujet(s)
Carcinome épidermoïde/traitement médicamenteux , Cétuximab/pharmacologie , Récepteurs ErbB/génétique , Tumeurs de la tête et du cou/traitement médicamenteux , Animaux , Antinéoplasiques/pharmacologie , Carcinome épidermoïde/enzymologie , Carcinome épidermoïde/génétique , Lignée cellulaire tumorale , Résistance aux médicaments antinéoplasiques , Femelle , Tumeurs de la tête et du cou/enzymologie , Tumeurs de la tête et du cou/génétique , Humains , Souris , Souris de lignée NOD , Polymorphisme de nucléotide simple , Répartition aléatoire , Transduction du signal , Carcinome épidermoïde de la tête et du cou , Tests d'activité antitumorale sur modèle de xénogreffe
2.
J Neurosci Methods ; 150(2): 212-27, 2006 Jan 30.
Article de Anglais | MEDLINE | ID: mdl-16095718

RÉSUMÉ

Deep brain stimulation, the electric stimulation of basal ganglia nuclei, is a treatment for movement disorders such as Parkinson's disease. The underlying mechanisms are studied in animals, e.g. rodents. Designs and materials of commercially available microelectrodes, as well as experimentally applied driving signals vary tremendously. We used finite integration modeling to compare the electric field and current density distributions induced by various electrodes. Current density or field strength "hot spots", which are located particularly at sites of high curvature and material interfaces coincided with corrosion and erosion at poles and insulation, respectively, as shown by scanning electron microscopy of stainless steel electrodes. Cell constants, i.e. geometry factors relating the electrode impedance to the specific medium conductivity, were calculated to determine the electrode voltage for a given stimulation current. Nevertheless, for electrodes of the same cell constant but of different geometry, current and field distributions may be very dissimilar. We found geometry-dependent limiting values of the stimulation current, above which electric tissue damage may occur. These values limit the reach of the stimulation signal for a given electrode geometry. Also, electrode geometries determine the shape of the stimulated tissue volume. This study provides tools for choosing the most appropriate geometry for targeting different-sized brain areas.


Sujet(s)
Stimulation cérébrale profonde/instrumentation , Champs électromagnétiques , Microélectrodes , Modèles neurologiques , Animaux , Mathématiques
3.
J Neurosci Methods ; 142(2): 251-65, 2005 Mar 30.
Article de Anglais | MEDLINE | ID: mdl-15698665

RÉSUMÉ

Deep brain stimulation (DBS) is a therapy of movement disorders including Parkinson's disease (PD). Commercially available electrodes for animal models of Parkinson's disease vary in geometry and material. We characterized such electrodes and found a drift in their properties within minutes and up to about 60 h after immersion in cell culture medium, both with and without a stimulation signal. Electrode properties could largely be restored by proteolytic treatment for platinum/iridium electrodes but not for stainless steel ones. Short-term drift and irreversible aging could be followed by impedance measurements. Aging was accompanied by metal corrosion and erosion of the plastic insulation. For both materials, the degradation rates depended on the current density at the electrode surfaces. Fourier analysis of the DBS pulse (60 micros, repetition rate 130 Hz) revealed harmonic frequencies spanning a band of more than three decades, with significant harmonics up to the MHz range. The band is located in a window imposed by electrode processes and capacitive cell membrane bridging at the low and high frequency ends, respectively. Even though electrode processes are reduced at higher frequencies they only vanish above 1 MHz and cannot be avoided. Therefore, the use of inert electrode materials is of special importance. The neurotoxicity of iron makes avoiding stainless steel electrodes imperative. Future developments need to avoid the use of corrosive materials and current density hot spots at the electrode surface, and to reduce low frequency components in the DBS pulses in order to diminish electrode processes.


Sujet(s)
Stimulation cérébrale profonde/instrumentation , Techniques électrochimiques/instrumentation , Microélectrodes , Encéphale/physiologie , Stimulation cérébrale profonde/méthodes , Conductivité électrique , Techniques électrochimiques/méthodes , Conception d'appareillage/instrumentation , Conception d'appareillage/méthodes
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...